Basel Net Income From Continuing Ops from 2010 to 2026
| BMGL Stock | 0.63 0.02 3.28% |
Net Loss | First Reported 2010-12-31 | Previous Quarter -10.9 M | Current Value -10.3 M | Quarterly Volatility 5.1 M |
Check Basel Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Basel Medical's main balance sheet or income statement drivers, such as Interest Income of 125.1 K, Depreciation And Amortization of 781.8 K or Interest Expense of 187.9 K, as well as many indicators such as Price To Sales Ratio of 8.98, Dividend Yield of 0.0 or PTB Ratio of 24.43. Basel financial statements analysis is a perfect complement when working with Basel Medical Valuation or Volatility modules.
Basel | Net Income From Continuing Ops | Build AI portfolio with Basel Stock |
Historical Net Income From Continuing Ops data for Basel Medical serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether Basel Medical Group represents a compelling investment opportunity.
Latest Basel Medical's Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of Basel Medical Group over the last few years. It is Basel Medical's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Basel Medical's overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
Basel Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | (335,945) | |
| Coefficient Of Variation | (1,532) | |
| Mean Deviation | 3,799,399 | |
| Median | 1,977,964 | |
| Standard Deviation | 5,146,640 | |
| Sample Variance | 26.5T | |
| Range | 14.2M | |
| R-Value | (0.66) | |
| Mean Square Error | 16.1T | |
| R-Squared | 0.43 | |
| Significance | 0 | |
| Slope | (669,628) | |
| Total Sum of Squares | 423.8T |
Basel Net Income From Continuing Ops History
About Basel Medical Financial Statements
Basel Medical investors utilize fundamental indicators, such as Net Income From Continuing Ops, to predict how Basel Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Loss | -10.9 M | -10.3 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of Basel Medical Correlation against competitors. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Basel Medical. Projected growth potential of Basel fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Basel Medical assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (0.51) | Revenue Per Share | Quarterly Revenue Growth 0.322 | Return On Assets | Return On Equity |
Investors evaluate Basel Medical Group using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Basel Medical's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Basel Medical's market price to deviate significantly from intrinsic value.
It's important to distinguish between Basel Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Basel Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Basel Medical's market price signifies the transaction level at which participants voluntarily complete trades.